Roche’s anti-TIGIT drug tiragolumab has failed a lung cancer study, denting enthusiasm for the programme just as there were signs that it was getting back on track after a series of ...

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three ...

Freedom of information request reference no: 01.FOI.23.030679 I note you seek access to the following information: *** New Request *** The combined data of Business Interests and Secondary Employment ...

Freedom of information request reference no: 01.FOI.23.029314 I note you seek access to the following information: Q1 - Can you please advise how many officers have rejoined the Met under your ...